Needle-Free Blood Draw Device Keeps IV Lines Open Through Intensive Pharmacokinetic Studies
A pilot study shows a needle-free blood collection device can sustain nine venous samples per visit through a single IV ...
A pilot study shows a needle-free blood collection device can sustain nine venous samples per visit through a single IV ...
A Phase 1 trial found that an eight-week dosing interval produced stronger and longer-lasting antibody responses against H5N1 influenza than ...
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
A Phase 1 trial found that combining the ATR inhibitor ceralasertib with the PARP inhibitor olaparib was generally well tolerated ...
A phase 1 trial found that an autologous combination of natural killer cells and tumor-primed T lymphocytes was safe and ...
The phase 1 GlutaPanc trial shows that l-glutamine can be safely combined with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ...
An investigational EGFR x HER3 antibody-drug conjugate showed promising efficacy and a manageable safety profile in previously treated EGFR-mutated lung ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine